Infectious Disease Oral Dissolvable Biosensor Development
Apr 22, 2020
Vancouver, Canada (April 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that further to...
Apr 22, 2020
Vancouver, Canada (April 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that further to...
Apr 20, 2020
Vancouver, Canada (April 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that it has...
Mar 25, 2020
Vancouver, Canada (March 25, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY) (FSE:4XT) (OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that an exclusive infectious disease...
Mar 20, 2020
Vancouver, Canada (March 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY) (FSE:4XT) (OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce updates to its infectious disease...
Mar 18, 2020
Vancouver, Canada (March 18, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce significant progress with respect to development...
Mar 3, 2020
Vancouver, Canada (March 03, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...
Feb 18, 2020
Vancouver, Canada (February 18, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...
Jan 27, 2020
Vancouver, Canada (January 27, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the Company has signed a...
Dec 6, 2019
Vancouver, Canada (December 6, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the development of Epilepsy treatment...
Nov 26, 2019
Vancouver, Canada (November 25, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the Company’s pharmaceutical grade extraction...
Nov 11, 2019
Vancouver, Canada (November 11, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide an update on the Company’s thin...
Nov 4, 2019
Vancouver, Canada (November 04, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that it has signed a term...
Hear about our latest research, products, exclusive partnerships & more.